<DOC>
	<DOCNO>NCT01758172</DOCNO>
	<brief_summary>From postoperative patient undergone pancreaticoduodenectomy ; 1 . To compare hemodynamic parameter patient administrate 5 % HA 6 % Voluven 2 . To assess efficacy treatment regard clinical outcome laboratory parameter patient 3 . To compare safety 2 intravenous colloid patient population</brief_summary>
	<brief_title>Comparison Hemodynamic Effects Two Colloid Therapies Post-operative Patients Undergoing Pancreaticoduodenectomy</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Subjects meet inclusion criterion participate study 1 . Agefrom 1875 year adult 2 . In immediate postoperative period pancreaticoduodenectomy 3 . Written inform consent admit ICU immediate postoperative patient Any patient meet one follow exclusion criterion may enter study . 1 . Refusal participate study 2 . Evidence preoperative oliguria ( Serum creatinine &gt; 1.5mmol/dL ) 3 . Known Severe congestive heart failure ( NYHAIII , IV ) 4 . Known severe respiratory disease ( PaO2/FiO2 &lt; 200 ) 5 . Known coagulopathy ( Platelet &lt; 100k/mm3 , aPTT &gt; 70 , PT ( INR ) &gt; 2.5 ) 6 . Known allergy hydroxyethyl starch 7 . Known pregnancy lactation 8 . Has participate clinical trial within 3months 9 . Any contraindication VoluvenÂ® albumin accord package insert .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>pancreaticoduodenectomy</keyword>
	<keyword>postoperative patient</keyword>
	<keyword>colloid</keyword>
	<keyword>albumin</keyword>
	<keyword>hetastarch</keyword>
</DOC>